DVS Sciences Raises $14.6M

The firm will use the financing to build up the manufacturing of its CyTOF-Maxpar platform for multiplexed single cell analysis.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories